CRISPR Therapeutics AG Share Price
NASDAQ: CRSPHealthcare
Live CRISPR Therapeutics AG Share Price Chart
O H L
CRISPR Therapeutics AG Performance Overview
Days Range
▼
$55.34Low
$56.97High
Markets Today
| Previous Close | $56.00 |
|---|---|
| Open | $56.23 |
| Volume | 1,159,987 |
| Day's Range | $55.34 - $56.97 |
| 52W Range | $44.12 - $78.48 |
| Market Cap | $5.23 B |
Historical Performance
| 1M Returns | -2.64 |
|---|---|
| 3M Returns | -0.54 |
| 6M Returns | +13.34 |
| 1Y Returns | -16.38 |
| 5Y Returns | -50.29 |
| 10Y Returns | NA |
CRISPR Therapeutics AG Fundamentals
| Market Cap | $5.23 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $3.51 M |
| ROE TTM | -0.30 |
| EPS TTM | $-4.76 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.99 |
| EBITDA | $-645.09 M |
| Profit Margin | -16569.77 |
| Market Cap | $5.23 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $3.51 M |
| ROE TTM | -0.30 |
| EPS TTM | $-4.76 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.99 |
| EBITDA | $-645.09 M |
| Profit Margin | -16569.77 |
CRISPR Therapeutics AG Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $865.00 K | $892.00 K | $889.00 K | $864.00 K | $1.46 M | $10.18 M |
| Gross Profit + | $865.00 K | $892.00 K | $889.00 K | $864.00 K | $1.46 M | $10.18 M |
| Operating Income | -$148.42 M | -$229.32 M | -$132.06 M | -$154.76 M | -$130.25 M | -$117.27 M |
| EBITDA | -$143.69 M | -$224.68 M | -$127.63 M | -$149.10 M | -$125.93 M | -$112.99 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $4.74 M | $4.65 M | $4.43 M | $5.66 M | $4.32 M | $4.28 M |
| Income Before Tax | -$134.89 M | -$207.26 M | -$105.82 M | -$130.00 M | -$122.09 M | -$90.19 M |
| Income Tax Expense | $1.11 M | $1.29 M | $619.00 K | $614.00 K | $839.00 K | $960.00 K |
| Net Income + | -$136.00 M | -$208.55 M | -$106.44 M | -$130.61 M | -$122.93 M | -$91.15 M |
| Net Profit Margin | -15722.08% | -23379.93% | -11973.12% | -15117.25% | -8431.48% | -895.33% |
CRISPR Therapeutics AG Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.72 M | $2.79 M | $3.01 M | $3.09 M | $3.12 M | $3.13 M |
| Reserve & Surplus | -$1.50 B | -$1.71 B | -$1.81 B | -$1.94 B | -$2.07 B | -$2.17 B |
| Non-Current Liabilities | $217.50 M | $214.22 M | $210.37 M | $194.31 M | $774.98 M | $771.32 M |
| Current Liabilities | $119.45 M | $104.36 M | $118.96 M | $149.12 M | $136.29 M | $132.90 M |
| Total Liabilities | $336.94 M | $318.59 M | $329.33 M | $343.43 M | $911.26 M | $904.22 M |
| Fixed Assets | $129.43 M | $124.93 M | $120.83 M | $115.85 M | $112.17 M | $108.07 M |
| Current Assets | $1.87 B | $1.73 B | $1.93 B | $1.99 B | $2.45 B | $2.37 B |
| Total Assets | $2.17 B | $2.03 B | $2.25 B | $2.27 B | $2.73 B | $2.65 B |
CRISPR Therapeutics AG Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$136.00 M | -$208.55 M | -$106.44 M | -$130.61 M | -$122.93 M | -$91.15 M |
| Operating Cash Flow | -$53.95 M | -$113.88 M | -$84.63 M | -$92.55 M | -$108.90 M | -$83.50 M |
| Investing Cash Flow | -$19.75 M | $69.98 M | -$119.23 M | $37.20 M | -$410.74 M | -$55.66 M |
| Financing Cash Flow | $10.59 M | $2.26 M | $296.77 M | $116.41 M | $591.91 M | $7.18 M |
| Change in Cash | -$63.07 M | -$41.56 M | $92.88 M | $61.06 M | $72.24 M | -$131.97 M |
CRISPR Therapeutics AG Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $133.74B | 190.39% | 30.70 | 32.94% | 0.00% |
 | $78.76B | -47.13% | 0.00 | -145.16% | 0.00% |
 | $1.60B | -91.03% | 0.00 | -609.85% | 0.00% |
 | $8.71M | -99.99% | 0.00 | NA | 0.00% |
 | $2.50B | -71.82% | 0.00 | -57.24% | 0.00% |
 | $563.15M | -93.70% | 0.00 | NA | 0.00% |
 | $10.16B | 464.75% | 0.00 | -28.69% | 0.00% |
| $2.50B | -71.82% | 0.00 | -57.24% | 0.00% |
| $1.60B | -91.03% | 0.00 | -609.85% | 0.00% |
 | $385.49M | -93.70% | 0.00 | -395.01% | 0.00% |
CRISPR Therapeutics AG Return Calculator
The CRISPR Therapeutics AG stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,920
Invested Amount$10,000
Est. Returns$-5,080
About CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
Popular Stocks
FAQs
What is the share price of CRISPR Therapeutics AG today?
CRISPR Therapeutics AG (CRSP) share price as of October 1, 2026 is $54.75. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of CRISPR Therapeutics AG?
Yes, Indian Investors can invest in the CRISPR Therapeutics AG (CRSP) Share by opening an international trading account with Angel One.
How can I purchase CRISPR Therapeutics AG shares in India?
Purchasing CRISPR Therapeutics AG (CRSP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying CRISPR Therapeutics AG (CRSP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of CRISPR Therapeutics AG?
Yes, you can purchase fractional shares of CRISPR Therapeutics AG (CRSP) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of CRISPR Therapeutics AG?
The market capitalization of CRISPR Therapeutics AG on October 1, 2026, is $5.23 B.
In which sector CRISPR Therapeutics AG belongs?
CRISPR Therapeutics AG operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in CRISPR Therapeutics AG stocks?
In order to invest in CRISPR Therapeutics AG (CRSP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
